Video Experimental Relacionado
Updated: Sep 10, 2025
10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
12.1K
Mecanismos moleculares contra la pérdida de peso exitosa y opciones de tratamiento prometedoras en la obesidad
Zsolt Szekeres1, Eszter Szabados2, Anita Pálfi2
1Department of Laboratory Medicine, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Biomedicines
|August 28, 2025
Resumen
La obesidad implica mecanismos moleculares complejos como la memoria metabólica y la epigenética que dificultan la pérdida de peso. Las terapias novedosas son prometedoras, pero la eficacia a largo plazo requiere más estudios para un manejo eficaz de la obesidad.
Área de la Ciencia:
- Mecanismos moleculares de la obesidad
- Trastornos del metabolismo
- Endocrinología
Sus antecedentes:
- La obesidad es un problema de salud complejo con causas multifactoriales que incluyen estilo de vida, genética y factores neuroendocrinos.
- A pesar de las intervenciones, la pérdida de peso sostenida sigue siendo un desafío importante.
- Comprender los mecanismos moleculares es crucial para desarrollar tratamientos efectivos contra la obesidad.
Objetivo del estudio:
- Revisar los conocimientos actuales sobre los mecanismos moleculares que impiden la pérdida de peso.
- Para resumir las estrategias terapéuticas emergentes para el control de la obesidad.
- Para proporcionar información sobre las complejidades del tratamiento de la obesidad.
Principales métodos:
- Revisión completa de la literatura de las bases de datos de PubMed, Scopus y Web of Science.
- La inclusión de artículos originales revisados por pares, revisiones sistemáticas y metanálisis.
- Centrarse en los estudios publicados en los últimos diez años (2015-2025), teniendo en cuenta las obras históricamente significativas.
Principales resultados:
- La obesidad es una condición crónica que requiere enfoques personalizados y multidisciplinarios.
- Los mecanismos moleculares clave incluyen la memoria metabólica, la epigenética (modificaciones de ADN / histona, microARN) y la disfunción del tejido adiposo.
- La disfunción del tejido adiposo contribuye a la inflamación y la resistencia a la insulina, exacerbando la obesidad.
- El equilibrio de los tipos de adipocitos (blanco, beige, marrón) influye en la regulación de la energía.
- Las nuevas intervenciones médicas muestran potencial para contrarrestar las barreras de la pérdida de peso.
Conclusiones:
- Las intervenciones combinadas (dieta, ejercicio, farmacoterapia) ofrecen potencial para el tratamiento de la obesidad.
- La eficacia y la seguridad a largo plazo de las intervenciones actuales y nuevas necesitan más investigación.
- Las estrategias personalizadas y multidisciplinarias son esenciales para el manejo eficaz de la obesidad.
Videos de Conceptos Relacionados
01:24Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
01:30Regulation of Food Intake
350
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
350
01:24Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
01:15Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
01:23Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K